Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults-Reference-Cited by-同舟云学术

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

Published:2006-10 Issue:4 Volume:4 Page:275-282
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Erondu Ngozi,Gantz Ira,Musser Bret,Suryawanshi Shailaja,Mallick Madhuja,Addy Carol,Cote Josee,Bray George,Fujioka Ken,Bays Harold,Hollander Priscilla,Sanabria-Bohórquez Sandra M.,Eng WaiSi,Långström Bengt,Hargreaves Richard J.,Burns H. Donald,Kanatani Akio,Fukami Takehiro,MacNeil Douglas J.,Gottesdiener Keith M.,Amatruda John M.,Kaufman Keith D.,Heymsfield Steven B.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference43 articles.

1. Gut hormone PYY(3-36) physiologically inhibits food intake;Batterham;Nature,2002

2. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus;Baskin;Diabetes,1999

3. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats;Cabrele;J. Biol. Chem.,2000

4. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats;Clark;Endocrinology,1984

5. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat;Cowley;Neuron,1999

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereochemistry-Driven Interactions of α,γ-Peptide Ligands with the Neuropeptide Y Y₄-Receptor;Journal of Medicinal Chemistry;2023-07-13

2. Neuropeptides Modulate Feeding via the Dopamine Reward Pathway;Neurochemical Research;2023-05-26

3. Les approches thérapeutiques non invasives de l’obésité : hier, aujourd’hui et demain;Nutrition Clinique et Métabolisme;2022-11

4. PET Imaging of the Neuropeptide Y System: A Systematic Review;Molecules;2022-06-09

5. Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity;Nutrition, Metabolism and Cardiovascular Diseases;2022-06